FDA greenlights Samsung S-Vue 3.02 dose reduction solution

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

Posição atual:
>
> This Story

starstarstarstarstar (1)
Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

X-Ray Homepage

Noritsu acquires R&F Imaging Systems Expands R&F presence from regional to national scale

CT and MR waiting times costing Canadians over $3 billion Need $4.4 billion to update imaging stock, says report

When it comes to enterprise imaging, having a 'vision' is the easy part Experts share frontline experiences at the SIIM meeting

FDA gives thumbs up for Canon's deep learning image reconstruction tech Suppresses noise and enhances signal for sharper images

The future of C-arms Insights from Gustavo Perez, president and CEO of image guided therapies at GE Healthcare

SEC probes Siemens, GE and Philips over business with China Lawsuit alleges OEMs worked together to fix prices on medical equipment

FDA gives thumbs-up to launch of ControlRad Trace Only solution that integrates with C-arms to reduce dose

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Study calls for better factoring-in of patient complexity in head CT scans Should consider complexity of associated billed patient encounters

Study shows 30 percent drop in unnecessary head CTs with BrainScope One May help ensure appropriate use of imaging

S-Vue 3.02 produces high quality images
while reducing dose exposure
for pediatric patients

FDA greenlights Samsung S-Vue 3.02 dose reduction solution

por John R. Fischer , Staff Reporter
The FDA has given the green light to Samsung’s S-Vue 3.02, an image post-processing engine equipped with an advanced noise-reduction algorithm for producing high-quality images at a fraction of the radiation dose used in pediatric patients.

The solution is capable of significantly reducing X-ray dose in various imaging exams to the point where it may potentially establish safer conditions for subjecting pediatric patients in need of additional scanning to repeat exposure.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“Constantly working to lower dose exposure is a top priority for radiologists and healthcare professionals, and Samsung’s ability to offer dose reduction across its suite of DR machines represents another breakthrough in medical imaging technology,” said David Legg, vice president and head of ultrasound and digital radiography business at NeuroLogica, the healthcare subsidiary of Samsung Electronics, in a statement “This new low-dose protocol is proof that we’re continuing to reduce radiation dose in our products. We are delighted that we are now able to offer this to the patients who are most vulnerable.”

S-Vue 3.02 is incorporated on Samsung’s digital radiography systems, GC85A and GM85, and provides spatially adaptive multi-scale processing, in addition to its advanced noise-reduction capabilities.

When applied in pediatric abdomen exams, Samsung observed a dose decline of up to 45 percent, as compared to the level of its previous IPE on the same X-ray systems. It also decreased exposure by 27 percent for pediatric skull procedures, and by 15.5 percent in pediatric chest exams.

The findings support Samsung’s objective to advance as low as reasonably achievable (ALARA) standards for ensuring minimal exposure to X-ray radiation.

“Findings of our clinical trial showed that use of Samsung’s S-Vue for pediatric chest images resulted in an overall image quality that was uncompromised even at a significantly reduced radiation exposure,” said Susan John, professor and chair of diagnostic and interventional imaging at McGovern Medical School at The University of Texas Health Science Center at Houston, in a statement. “The reduction in radiation dose potentially enables repeat radiographs for better follow-up in patients from infancy into adulthood, while assisting us in confident diagnosis.”

The limited phantom and clinical study results were retrieved from the performance of routine PA chest radiography and abdominal radiography for average adults and pediatric abdominal, chest and skull radiography, excluding patients under one month old.

Back to HCB News
  Pages: 1

X-Ray Homepage


You Must Be Logged In To Post A Comment